483
L'Oreal USA Products IncFDA 483 - L'Oreal USA Products Inc - February 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of L'Oreal USA Products Inc in Somerset, NJ, identified one observation related to the firm's quality control unit. The observation noted that finished goods testing documentation, including for CeraVe Skin Renewing Day Cream SPF30, was recorded on uncontrolled papers lacking dates, traceability, and QC review. This indicates a failure to fully follow established procedures for record control.
Open in Dashboard
ID · c0c250ef-330c-4de9-83bb-35c7478f8627